Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study by Xu, Jianming, Prof, Shen, Lin, Prof, Zhou, Zhiwei, Prof, Li, Jie, Prof, Bai, Chunmei, Prof, Chi, Yihebali, Prof, Li, Zhiping, Prof, Xu, Nong, Prof, Li, Enxiao, Prof, Liu, Tianshu, Prof, Bai, Yuxian, Prof, Yuan, Ying, Prof, Li, Xingya, Prof, Wang, Xiuwen, Prof, Chen, Jia, Prof, Ying, Jieer, Prof, Yu, Xianjun, Prof, Qin, Shukui, Prof, Yuan, Xianglin, Prof, Zhang, Tao, Prof, Deng, Yanhong, Prof, Xiu, Dianrong, Prof, Cheng, Ying, Prof, Tao, Min, Prof, Jia, Ru, MD, Wang, Wei, MD, Li, Jing, MD, Fan, Songhua, MD, Peng, Mengye, PhD, Su, Weiguo, PhD

Get full text

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised,... by Huang, Jing, Prof, Xu, Jianming, Prof, Chen, Yun, MD, Zhuang, Wu, MD, Zhang, Yiping, Prof, Chen, Zhendong, Prof, Chen, Jia, Prof, Zhang, Helong, Prof, Niu, Zuoxing, Prof, Fan, Qingxia, Prof, Lin, Lizhu, Prof, Gu, Kangsheng, Prof, Liu, Ying, MD, Ba, Yi, Prof, Miao, Zhanhui, MD, Jiang, Xiaodong, MD, Zeng, Ming, Prof, Chen, Jianhua, Prof, Fu, Zhichao, MD, Gan, Lu, MD, Wang, Jun, Prof, Zhan, Xianbao, Prof, Liu, Tianshu, Prof, Li, Zhiping, Prof, Shen, Lin, Prof, Shu, Yongqian, Prof, Zhang, Tao, PhD, Yang, Qing, MD, Zou, Jianjun, MD

Get full text

Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study by Xu, Jianming, Prof, Shen, Lin, Prof, Bai, Chunmei, Prof, Wang, Wei, MD, Li, Jie, Prof, Yu, Xianjun, Prof, Li, Zhiping, Prof, Li, Enxiao, Prof, Yuan, Xianglin, Prof, Chi, Yihebali, Prof, Yin, Yongmei, Prof, Lou, Wenhui, Prof, Xu, Nong, Prof, Bai, Yuxian, Prof, Zhang, Tao, Prof, Xiu, Dianrong, Prof, Wang, Xiuwen, Prof, Yuan, Ying, Prof, Chen, Jia, Prof, Qin, Shukui, Prof, Jia, Ru, MD, Lu, Ming, MD, Cheng, Yuejuan, MD, Zhou, Zhiwei, Prof, Li, Jing, MD, He, James, MD, Su, Weiguo, PhD

Get full text

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase... by Xuan, Li, MD, Wang, Yu, Prof, Huang, Fen, MD, Fan, Zhiping, MD, Xu, Yajing, Prof, Sun, Jing, Prof, Xu, Na, MD, Deng, Lan, MD, Li, Xudong, MD, Liang, Xinquan, Prof, Luo, Xiaodan, MD, Shi, Pengcheng, MD, Liu, Hui, MD, Wang, Zhixiang, MD, Jiang, Ling, MD, Yu, Chunzi, MD, Zhou, Xuan, MD, Lin, Ren, MD, Chen, Yan, MD, Tu, Sanfang, MD, Huang, Xiaojun, Prof, Liu, Qifa, Prof

Get full text

Structure‐Activity Relationship Studies of Hydantoin‐Cored Ligands for Smoothened Receptor by Liu, Yang, Zhou, Fang, Ding, Kang, Xue, Dongxiang, Zhu, Zhihao, Li, Cuixia, Li, Fei, Xu, Yueming, Xu, Fei, Le, Zhiping, Zhao, Suwen, Tao, Houchao

Get full text